The recent research findings concerning syndromes of muscle wasting, malnutrition, and inflammation in individuals with chronic kidney disease (CKD) or acute kidney injury (AKI) have led to a need for new terminology. To address this need, the International Society of Renal Nutrition and Metabolism (ISRNM) convened an expert panel to review and develop standard terminologies and definitions related to wasting, cachexia, malnutrition, and inflammation in CKD and AKI. The ISRNM expert panel recommends the term ‘protein–energy wasting’ for loss of body protein mass and fuel reserves. ‘Kidney disease wasting’ refers to the occurrence of protein–energy wasting in CKD or AKI regardless of the cause. Cachexia is a severe form of protein–energy wasting that occurs infrequently in kidney disease. Protein–energy wasting is diagnosed if three characteristics are present (low serum levels of albumin, transthyretin, or cholesterol), reduced body mass (low or reduced body or fat mass or weight loss with reduced intake of protein and energy), and reduced muscle mass (muscle wasting or sarcopenia, reduced mid-arm muscle circumference). The kidney disease wasting is divided into two main categories of CKD- and AKI-associated protein–energy wasting. Measures of chronic inflammation or other developing tests can be useful clues for the existence of protein–energy wasting but do not define protein–energy wasting. Clinical staging and potential treatment strategies for protein–energy wasting are to be developed in the future.

Protein-energy malnutrition (PEM) and inflammation are common and usually concurrent in maintenance dialysis patients. Many factors that appear to lead to these 2 conditions overlap, as do assessment tools and such criteria for detecting them as hypoalbuminemia. Both these conditions are related to poor dialysis outcome. Low appetite and a hypercatabolic state are among common features. PEM in dialysis patients has been suggested to be secondary to inflammation; however, the evidence is not conclusive, and an equicausal status or even opposite causal direction is possible. Hence, malnutrition-inflammation complex syndrome (MICS) is an appropriate term. Possible causes of MICS include comorbid illnesses, oxidative and carbonyl stress, nutrient loss through dialysis, anorexia and low nutrient intake, uremic toxins, decreased clearance of inflammatory cytokines, volume overload, and dialysis-related factors. MICS is believed to be the main cause of erythropoietin hyporesponsiveness, high rate of cardiovascular atherosclerotic disease, decreased quality of life, and increased mortality and hospitalization in dialysis patients. Because MICS leads to a low body mass index, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a "reverse epidemiology" of cardiovascular risks can occur in dialysis patients. Therefore, obesity, hypercholesterolemia, and increased blood levels of creatinine and homocysteine appear to be protective and paradoxically associated with a better outcome. There is no consensus about how to determine the degree of severity of MICS or how to manage it. Several diagnostic tools and treatment modalities are discussed. Successful management of MICS may ameliorate the cardiovascular epidemic and poor outcome in dialysis patients. Clinical trials focusing on MICS and its possible causes and consequences are urgently required to improve poor clinical outcome in dialysis patients.

Protein-energy wasting (PEW), a term proposed by the International Society of Renal Nutrition and Metabolism (ISRNM), refers to the multiple nutritional and catabolic alterations that occur in chronic kidney disease (CKD) and associate with morbidity and mortality. To increase awareness, identify research needs, and provide the basis for future work to understand therapies and consequences of PEW, ISRNM provides this consensus statement of current knowledge on the etiology of PEW syndrome in CKD. Although insufficient food intake (true undernutrition) due to poor appetite and dietary restrictions contribute, other highly prevalent factors are required for the full syndrome to develop. These include uremia-induced alterations such as increased energy expenditure, persistent inflammation, acidosis, and multiple endocrine disorders that render a state of hypermetabolism leading to excess catabolism of muscle and fat. In addition, comorbid conditions associated with CKD, poor physical activity, frailty, and the dialysis procedure per se further contribute to PEW.

Acute renal failure (ARF) in the critically ill has been the topic of numerous reports over the past four decades. Many of these reports have focused on the associated high mortality rates; observational data from a broad range of centers have suggested in-hospital mortality rates in excess of 50% in most reported series¹ x 1 Hou, S.H., Bushinsky, D.A., Wish, J.B. et al. Hospital-acquired renal insufficiency: A prospective study. Am J Med. 1983; 74: 243–248 Abstract | Full Text PDF | PubMed | Scopus (862) | Google Scholar See all References ^{, 2} x 2 Shusterman, N., Strom, B.L., Murray, T.G. et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med. 1987; 83: 65–71 Abstract | Full Text PDF | PubMed | Scopus (283) | Google Scholar See all References ^{, 3} x 3 Brivet, F.G., Kleinknecht, D.J., Loirat, P., and Landais, P.J. Acute renal failure in intensive care units–causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med. 1996; 24: 192–198 Crossref | PubMed | Scopus (691) | Google Scholar See all References ^{, 4} x 4 Liano, F. and Pascual, J. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996; 50: 811–818 Abstract | Full Text PDF | PubMed | Scopus (672) | Google Scholar See all References ^{, 5} x 5 Mccarthy, J.T. Prognosis of patients with acute renal failure in the intensive-care unit: A tale of two eras. Mayo Clin Proc. 1996; 71: 117–126 Abstract | Full Text | Full Text PDF | PubMed | Scopus (155) | Google Scholar See all References ^{, 6} x 6 Liano, F., Junco, E., Pascual, J. et al. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. 1998; 66: S16–24 Google Scholar See all References ^{, 7} x 7 Silvester, W., Bellomo, R., and Cole, L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001; 29: 1910–1915 Crossref | PubMed | Scopus (250) | Google Scholar See all References ^{, 8} x 8 Clermont, G., Acker, C.G., Angus, D.C. et al. Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int. 2002; 62: 986–996 Abstract | Full Text | Full Text PDF | PubMed | Scopus (237) | Google Scholar See all References ^{, 9} x 9 Metcalfe, W., Simpson, M., Khan, I.H. et al. Acute renal failure requiring renal replacement therapy: Incidence and outcome. QJM. 2002; 95: 579–583 Crossref | PubMed | Google Scholar See all References ^{, 10} x 10 Morgera, S., Kraft, A.K., Siebert, G. et al. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis. 2002; 40: 275–279 Abstract | Full Text | Full Text PDF | PubMed | Scopus (200) | Google Scholar See all References . Identification of risk factors, comparison of severity scores, and comparisons of nonrandomized treatment strategies (e.g., diuretic agents, dopamine, dialysis modality) have dominated this literature¹¹ x 11 Chertow, G.M., Christiansen, C.L., Cleary, P.D. et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med. 1995; 155: 1505–1511 Crossref | PubMed | Scopus (320) | Google Scholar See all References ^{, 12} x 12 Chertow, G.M., Sayegh, M.H., Allgren, R.L., and Lazarus, J.M. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med. 1996; 101: 49–53 Abstract | Full Text PDF | PubMed | Scopus (120) | Google Scholar See all References ^{, 13} x 13 Chertow, G.M., Lazarus, J.M., Paganini, E.P. et al. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol. 1998; 9: 692–698 PubMed | Google Scholar See all References ^{, 14} x 14 Denton, M.D., Chertow, G.M., and Brady, H.R. “Renal-dose” dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int. 1996; 50: 4–14 Abstract | Full Text PDF | PubMed | Scopus (225) | Google Scholar See all References ^{, 15} x 15 Fiaccadori, E., Lombardi, M., Leonardi, S. et al. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol. 1999; 10: 581–593 PubMed | Google Scholar See all References ^{, 16} x 16 Fortescue, E.B., Bates, D.W., and Chertow, G.M. Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. Kidney Int. 2000; 57: 2594–2602 Abstract | Full Text | Full Text PDF | PubMed | Scopus (136) | Google Scholar See all References ^{, 17} x 17 Tonelli, M., Manns, B., and FELLER-KOPMAN, D. Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis. 2002; 40: 875–885 Abstract | Full Text | Full Text PDF | PubMed | Scopus (234) | Google Scholar See all References ^{, 18} x 18 Mehta, R.L., Pascual, M.T., Gruta, C.G. et al. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol. 2002; 13: 1350–1357 Crossref | PubMed | Scopus (234) | Google Scholar See all References ^{, 19} x 19 Neveu, H., Kleinknecht, D., Brivet, F. et al. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant. 1996; 11: 293–299 Crossref | PubMed | Scopus (255) | Google Scholar See all References ^{, 20} x 20 Liano, F. and Pascual, J. Outcomes in acute renal failure. Semin Nephrol. 1998; 18: 541–550 PubMed | Google Scholar See all References ^{, 21} x 21 Mehta, R.L., Mcdonald, B., Gabbai, F. et al. Nephrology consultation in acute renal failure: Does timing matter?. Am J Med. 2002; 113: 456–461 Abstract | Full Text | Full Text PDF | PubMed | Scopus (126) | Google Scholar See all References .